Skip to content

Amylase Test

by Em Diagnostic Systems, Inc.

510(k) K923677

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK923677 Date9 Sep 1992ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JFJ
Device Class
Class II
Regulation
21 CFR Part 862.1070
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Amylase Test is a device intended to measure the activity of the enzyme amylase in serum and urine. These measurements are used primarily for the diagnosis and treatment of pancreatitis, which is an inflammation of the pancreas.

This device is classified as a Class II catalytic method for amylase under regulation number 862.1070. It received FDA 510(k) clearance on September 9, 1992, under submission K923677.

Other devices from Em Diagnostic Systems, Inc.

See all devices from Em Diagnostic Systems, Inc. →

Questions

AI-generated answers, 25 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary clinical purpose of the Amylase Test?

    This device is designed to measure the activity of the enzyme amylase within serum and urine samples. These measurements are used by clinicians primarily to aid in the diagnosis and management of pancreatitis, which is an inflammation of the pancreas.

  • How is this device classified for regulatory purposes?

    The Amylase Test is classified as a Class II catalytic method for amylase under regulation number 862.1070. It received FDA 510(k) clearance on September 9, 1992, under submission number K923677.

  • Which medical specialty oversees this diagnostic test?

    The device falls under the Clinical Chemistry medical specialty. This classification is based on its function as a catalytic method for measuring enzyme activity in biological fluids.